vimarsana.com
Home
Live Updates
Phase 2 clinical trial of DS-1211 begins for individuals wit
Phase 2 clinical trial of DS-1211 begins for individuals wit
Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum
A Phase 2 clinical trial has started of DS-1211 in individuals with Pseudoxanthoma Elasticum (PXE), a rare multisystem genetic disease that causes calcium deposits in soft tissue resulting in considerable morbidity.
Related Keywords
Michael Jackson ,
Daiichi Sankyo ,
Sanford Burnham Prebys ,
Pseudoxanthoma Elasticum ,
Emily Henderson ,
Chemical Genomics Prebys Center ,
Institute Conrad Prebys Center ,
Prebys Center ,
Sanford Burnham ,
Luis Mill ,
Discovery Industry Focus ,
Conrad Prebys Center ,
Chemical Genomics ,
Clinical Trial ,
Ecalcification ,
Calcium ,
Dancer ,
Drug Discovery ,
Enetic ,
Olecule ,
Mh ,
Research ,